of Medicine, University of Oxford, Oxford, UK
The rapid weight regain during medication-free periods may offset any theoretical benefits
Investigation into Unauthorized Production As for the investigation into unauthorized production of compounded drugs, the focus centers on: Authorities are investigating allegations that compounded drugs contain unknown impurities , which may pose health risks to consumers
Both medications can have side effects
In a statement to CBS News about this lawsuit and others against it, Novo Nordisk said in part, "The known risks and benefits of semaglutide and liraglutide medicines are described in their FDA-approved product labeling." The company wrote that "the allegations in the lawsuits are without merit" and said it intends to "vigorously defend against these claims." Novo Nordisk also said semaglutide, the drug sold under the Ozempic and Wegovy brand names, has been extensively examined in robust clinical development programs and large real world evidence studies